CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending… Read More
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending… Read More
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down… Read More
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma… Read More
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While… Read More
Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of… Read More
Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game… Read More
Decision Appropriately Balances Access to Treatment with the Need for More… Read More
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting… Read More
Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control… Read More
Drug Companies Increased Prices on 785 Brand Name Products in First Month of… Read More
Next FDA Commissioner Must Promote Competition, Transparency And Value In The… Read More
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers… Read More